Depression trials recruiting in California

All Depression trials nationally

Cities in California

Recruiting trials in California

• A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations
  NCT06367764 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Palo Alto, San Francisco
• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT07115329 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · California: Montclair, Oceanside, Redlands, San Francisco
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
  NCT07592689 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Orange, San Diego, San Francisco, Santa Monica
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
  NCT03887715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Burlingame, Colton, Costa Mesa, La Jolla
• A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
  NCT06906939 · Phase: Early Phase 1 · Ages: 50 Years to 95 Years · Sex: All (male and female) · California: Los Angeles
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
  NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Bellflower, Culver City, Orange, Riverside
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
  NCT06775379 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Glendale, Huntington Beach, Irvine, Los Angeles
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Bellflower, La Jolla, San Diego, Sherman Oaks
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Moorpark, Orange
• A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
  NCT07716098 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Redlands
• A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
  NCT07573176 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Bellflower, Glendale, Oceanside, Orange
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
  NCT06793397 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · California: Glendale, Imperial, Los Angeles, Orange
• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
  NCT06696755 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Anaheim, Garden Grove, Montclair, Oceanside
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  NCT04777357 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · California: Anaheim, Beverly Hills, Chino, Culver City
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
  NCT07276997 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Anaheim, Imperial, Lemon Grove, Long Beach
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
  NCT06524830 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Garden Grove, Glendale, La Jolla, Los Alamitos
• A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
  NCT07621237 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Chino, Lemon Grove, Orange, San Diego
• A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
  NCT07610473 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Bellflower, Costa Mesa, Lafayette
• A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
  NCT07300969 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Oceanside, San Diego, Torrance
• A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
  NCT07105111 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · California: Chino, Fountain Valley, Fresno, Long Beach
• A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
  NCT07065240 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Chino, Garden Grove, Glendale, Redlands
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
  NCT06223880 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Bellflower, Lafayette, Oceanside, Redlands
• A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT07196501 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Oceanside, Orange, San Jose
• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
  NCT07284667 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Chino, Glendale, La Jolla, Orange
• ALTO-100 in Bipolar Disorder With Depression (BD-D)
  NCT06656416 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Imperial, Los Angeles, Mather, Oceanside
• ALTO-207 in Adults With Treatment-resistant Depression (TRD)
  NCT07553637 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Chino, Oakland, Oceanside, Palo Alto
• ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
  NCT07528014 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla, Laguna Hills
• Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk
  NCT07025720 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 25 Years · Sex: All (male and female) · California: Sacramento
• Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
  NCT05685368 · Phase: Phase 1, Phase 2 · Ages: 14 Years to 21 Years · Sex: All (male and female) · California: Los Angeles
• An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
  NCT07792837 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: San Diego
• Assessing Improvements in Mood and Sleep Trial
  NCT06639477 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · California: Los Angeles
• Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2)
  NCT06753123 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Better Sleep Study
  NCT06139861 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · California: Los Angeles
• Biomarker-guided rTMS for Treatment Resistant Depression
  NCT04041479 · Phase: Phase 3 · Ages: 22 Years to 65 Years · Sex: All (male and female) · California: Stanford
• Biomarkers of Depression and Treatment Response
  NCT04581902 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: San Francisco
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
  NCT05869682 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Male · California: Duarte
• CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
  NCT07679074 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: Female · California: San Francisco
• Characterization and Treatment of Adolescent Depression
  NCT03388606 · Phase: Not specified · Ages: 11 Years to 25 Years · Sex: All (male and female) · California: Los Angeles
• Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
  NCT02434393 · Phase: Not specified · Ages: 65 Years and older · Sex: All (male and female) · California: San Francisco
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
  NCT07484217 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Bellflower, Chino, Glendale, Imperial
• Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression
  NCT07127913 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · California: San Francisco
• Cognition and Behavior With Sham Accelerated TMS
  NCT07397858 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 25 Years · Sex: All (male and female) · California: Sacramento
• Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
  NCT06526078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: Oakland
• Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
  NCT05682677 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: La Jolla
• Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
  NCT05176392 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: San Diego
• Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
  NCT05377177 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: San Diego
• Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
  NCT07226661 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Garden Grove
• E-Mindfulness Approaches for Living After Breast Cancer
  NCT06748222 · Phase: Phase 3 · Ages: 18 Years to 50 Years · Sex: All (male and female) · California: Anaheim, Antioch, Bakersfield, Baldwin Park
• Effectiveness of the SoundHeal Multi-Sensory Integrative Therapy Among Justice-Involved Youth
  NCT07364799 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · California: San Luis Obispo
• Efficacy of a Multi-level School Intervention for LGBTQ Youth
  NCT05541406 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 20 Years · Sex: All (male and female) · California: El Monte, Glendale, Inglewood, La Crescenta-Montrose
• Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
  NCT06273527 · Phase: Phase 2, Phase 3 · Ages: 21 Years to 55 Years · Sex: All (male and female) · California: San Diego
• Enhancing Veteran-Clinical Collaboration in VA PRRCs
  NCT06898879 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego, West Los Angeles
• Evaluating tDCS Brain-stimulation in Depression Using MRI
  NCT05598034 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 55 Years · Sex: All (male and female) · California: Los Angeles
• Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
  NCT06830044 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Garden Grove, Lemon Grove, Orange, San Jose
• Filipino Family Health Initiative 1.0
  NCT06569303 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years and older · Sex: All (male and female) · California: Pasadena
• Health And Response: Digital Markers for Outcomes in Perinatal Depression Treatment Study
  NCT07577947 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: Los Angeles
• HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
  NCT06175104 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• Improving Behavioral Health for Caregivers and Children After Pediatric Injury
  NCT06856057 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles
• In-patient SCC TMS
  NCT05645575 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Los Angeles
• Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression
  NCT05329441 · Phase: Not specified · Ages: 14 Years to 21 Years · Sex: All (male and female) · California: Los Angeles
• Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans
  NCT05996900 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Stanford
• Ketamine for Veterans With Parkinson's Disease
  NCT06231563 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · California: San Francisco
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Glendale, Los Angeles, Oceanside, Orange
• Maintenance rTMS for Depression (Maitr-De)
  NCT06938841 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: San Diego
• Meditative Neurofeedback for Depression
  NCT06675240 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: La Jolla
• Mindfulness Engaged Neurostimulation for Depression (MEND II)
  NCT07512284 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: San Diego
• Model-based Electrical Brain Stimulation
  NCT05327387 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
  NCT06372964 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · California: Anaheim, Redlands, Sacramento, San Diego
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
  NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Bellflower, Culver City, Garden Grove, Lemon Grove
• NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06911112 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Glendale, Irvine, Redlands, San Francisco
• NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06963021 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Chino, Los Angeles, Stanford
• Near Infrared Spectroscopy (NIRS) for Assessment of Depression
  NCT04061148 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Optimizing Brain Excitability in Depression
  NCT07242105 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Iowa City, Stanford
• Pain and Major Depressive Disorder
  NCT04556890 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Los Angeles
• Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
  NCT06073886 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Westwood, Los Angeles
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
  NCT06559306 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · California: Anaheim, Colton, Encino, Glendale
• Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings
  NCT07155707 · Phase: Not applicable (e.g. observational or device study) · Ages: 5 Years to 14 Years · Sex: All (male and female) · California: Monterey, Stanford
• Positive Affect Treatment for Adolescents With Early Life Adversity
  NCT06273137 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 16 Years · Sex: All (male and female) · California: Irvine
• Postpartum Education Via Artificial Intelligence for Recovery and Loneliness: A Randomized Controlled Trial
  NCT07223736 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: La Jolla
• Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements
  NCT07294924 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · California: Los Angeles, Sunnyvale
• Probiotic Administration for Adolescent Depression
  NCT06898788 · Phase: Early Phase 1 · Ages: 15 Years to 24 Years · Sex: All (male and female) · California: San Francisco
• Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy
  NCT05908565 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · California: Los Angeles
• Psilocybin Therapy for Depression in Parkinson's Disease
  NCT06455293 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · California: San Francisco
• Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
  NCT07573150 · Phase: Not specified · Ages: 3 Years to 17 Years · Sex: All (male and female) · California: San Francisco
• RCT for Latina Mental Health Using Web-Based Apps
  NCT06874790 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · California: Los Angeles
• RCT of Psilocybin-assisted CBT for Depression
  NCT07281352 · Phase: Phase 1, Phase 2 · Ages: 21 Years to 60 Years · Sex: All (male and female) · California: Los Angeles
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · California: San Diego, Santa Rosa
• Regulation of Affect and Physiology in Depression
  NCT06345859 · Phase: Phase 2 · Ages: 18 Years to 27 Years · Sex: All (male and female) · California: Los Angeles
• S.T.A.N.D. Alacrity Center Signature Project
  NCT05591937 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · California: Los Angeles
• SUpport From PEeRs to Expand Access Study - Community
  NCT07186816 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 100 Years · Sex: All (male and female) · California: San Francisco
• Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
  NCT06376734 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Sunnyvale
• Sleep Health in U.S. Marines
  NCT07420205 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Diego
• Sleep Mechanisms Of Regulating Emotions
  NCT06373718 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Palo Alto
• Sleep TMS for Depression
  NCT06824415 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Stanford
• Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction
  NCT06678880 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: Female · California: San Diego
• Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
  NCT07217223 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · California: San Diego
• Stratified Pharmacological Approaches for Regulating Circuit-Level Effects
  NCT07022405 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Palo Alto
• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
  NCT06633016 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Anaheim, Encino, Glendale, Long Beach
• Study of ALTO-300 in MDD
  NCT05922878 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · California: Bellflower, Glendale, Lafayette, Los Angeles
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
  NCT05850689 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · California: Pico Rivera